Effect of 17beta-hydroxysteroid dehydrogenase type 2 inhibitor on bone strength in ovariectomized cynomolgus monkeys.
Effect of 17beta-hydroxysteroid dehydrogenase type 2 inhibitor on bone strength in ovariectomized cynomolgus monkeys.
复制标题
17β-羟基类固醇脱氢酶 2 型抑制剂对去卵巢食蟹猴骨强度的影响。
DOI:
--
复制
发表时间:
2008
影响因子:
1.9
通讯作者:
B. Dixon
中科院分区:
文献类型:
--
作者:
Bagi Cm;J. Wood;D. Wilkie;B. Dixon
In both sexes, a reduction in sex steroid production with aging impairs the musculoskeletal system. The goal of our study was to test the ability of WH-9062, a novel non-steroidal small molecule inhibitor of the 17beta-Hydroxysteroid Dehydrogenase type 2 enzyme, to maintain or improve bone strength without raising serum levels of testosterone or estradiol. Mature, female cynomolgus monkeys with sealed growth plates were allocated into six groups: Sham controls, OVX controls, OVX+Premarin (15 mg/kg/d), and three groups of OVX monkeys receiving WH-9062 at 1, 5 and 25 mg/kg/day. All treatments were administered by daily oral dosing for 23 weeks. Changes in lipid profile caused by OVX were corrected with WH-9062 and included lowering total of cholesterol and non-HDL cholesterol, and maintenance of initial plasma levels of HDL cholesterol. Only the highest dose of WH-9062 lowered bone resorption relative to OVX controls. Elevated bone specific alkaline phosphatase, osteocalcin, BMC and dynamic bone histomorphometry data resulted in desirable bone balance and bone strength. The obtained results support our theory that inhibition of 17beta-HSD type 2 resulted in high local estrogen and/or testosterone levels leading to maintenance of bone formation and bone strength. Collectively, our data demonstrated that the treatment paradigm that utilizes tissue selectivity and receptor bioavailability in conversion of inactive hormones to active forms could be achieved and could result in desirable effects on target tissues such as bone and muscles.
登录
查看更多内容
影响因子:
4.9
作者:
Longcope,C;Baker,RS;Hui,SL;JohnstonJr,CC
通讯作者:
JohnstonJr,CC
DOI:
10.1210/jcem.79.2.8045949
发表时间:
1994
期刊:
The Journal of clinical endocrinology and metabolism
影响因子:
--
作者:
Prestwood,KM;Pilbeam,CC;Burleson,JA;Woodiel,FN;Delmas,PD;Deftos,LJ;Raisz,LG
通讯作者:
Raisz,LG
影响因子:
6.7
作者:
Simpson,EvanR
通讯作者:
Simpson,EvanR
DOI:
10.1172/jci113201
发表时间:
1987
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
Slemenda,C;Hui,SL;Longcope,C;Johnston,CC
通讯作者:
Johnston,CC
影响因子:
4.1
作者:
Guo, XE;Kim, CH
通讯作者:
Kim, CH